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*Author for correspondence (e-mail: dswilliams@ucsd.edu)Guanylate cyclases play an essential role in the recovery of
vertebrate photoreceptor cells after light activation. Here,
we have investigated how one such guanylate cyclase,
RetGC-1, is distributed within light- and dark-adapted rod
photoreceptor cells. Guanylate cyclase activity partitioned
with the photoreceptor outer segment (OS) cytoskeleton in
a light-sensitive manner. RetGC-1 was found to bind actin
filaments in actin blot overlays, suggesting a mechanism for
its association with the OS cytoskeleton. In retinal sections,
this enzyme was immunodetected only in the OSs, where it
appeared to be distributed throughout the disk
membranes.
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SUMMARYINTRODUCTION
Light activation of a vertebrate photoreceptor cell leads to
hydrolysis of intracellular cyclic GMP and closure of the cyclic
GMP-gated cation channels in the plasma membrane of the
photoreceptor outer segment (reviewed by Lagnado and
Baylor, 1992; Yarfitz and Hurley, 1994). Recovery from this
response requires the synthesis of cyclic GMP by guanylate
cyclase. Guanylate cyclase activity in the outer segments is
sensitive to Ca2+ concentration (Lolley and Racz, 1982; Pepe
et al., 1986; Koch and Stryer, 1988; Hakki and Sitaramayya,
1990), as a result of regulation by Ca2+-binding proteins,
known as guanylate cyclase activating proteins (GCAPs). Two
guanylate cyclases (Shyjan et al., 1992; Goraczniak et al.,
1994; Lowe et al., 1995; Yang et al., 1995) and three GCAPs
(Dizhoor et al., 1994, 1995; Gorczyca et al., 1994, 1995; Pal-
czewski et al., 1994; Pozdnyakov et al., 1995) have now been
identified in photoreceptor cells. 
To understand fully how photoreceptor guanylate cyclase
activity is regulated, it is essential to determine how the
enzyme is distributed within the cell. From earlier studies it
was thought that most of the guanylate cyclase activity is asso-
ciated with the outer segment cytoskeleton and localized within
the axoneme that connects the outer segment to the inner
segment (Krishnan et al., 1978; Fleischmann and Denisevich,
1979; Fleischmann et al., 1980). Later studies developed pro-
cedures that resulted in solubilization of some of the guanylate
cyclase activity, which could then be purified (Hakki and
Sitaramayya, 1990; Horio and Murad, 1991; Hayashi and
Yamazaki, 1991; Koch, 1991; Aparicio and Applebury, 1995).
In addition, two immunocytochemical studies with primate
retinas indicate that photoreceptor cell guanylate cyclase is notrestricted to the axoneme (Dizhoor et al., 1994; Liu et al.,
1994). 
In the present study, we have examined the partitioning of
guanylate cyclase and its immunolocalization within both
light- and dark-adapted rod photoreceptor cells. We report on
light-sensitive partitioning and suggest an explanation for the
enzyme’s detergent insolubility. We also describe the spatial
distribution of the enzyme within the rod outer segment by
comparing it with that of peripherin/rds, a protein found only
in the disk rims (Molday et al., 1987; Arikawa et al., 1992).
MATERIALS AND METHODS
Antibodies
Monoclonal antibodies were made against actin-binding proteins in
bovine photoreceptor outer segments (OSs). Dark-adapted OSs from
300 retinas were purified on sucrose gradients as described previously
(Azarian et al., 1995). They were homogenized in buffer A plus 1%
Triton X-100. Buffer A contained 20 mM Tris-HCl, pH 7.5, 100 mM
KCl, 10 mM MgCl2, 1 mM ethylene glycol-bis ( b -aminoethyl ether
N,N,N ¢ ,N¢ -tetraacetic acid) (EGTA), 1 mM dithiothreitol (DTT), 1
mM phenylmethylsulfonyl fluoride (PMSF), 1 m M pepstatin A
(Boehringer-Mannheim, Indianapolis, IN), 24 m M leupeptin
(Boehringer-Mannheim, Indianapolis, IN) and 10 m g/ml phalloidin
(Molecular Probes, Eugene, OR). All chemicals were purchased from
Sigma Chemical Co., St Louis, MO, unless otherwise noted. After
centrifugation at 361,000 g for 1 hour, the pellet was washed in the
same buffer twice more. The final cytoskeletal pellet was extracted
with buffer A plus 1 M KCl. The resulting high-salt extract was
dialyzed against buffer A, centrifuged at 361,000 g for 1 hour to
remove any aggregates, incubated for 30 minutes on ice with 500 m g
of filamentous actin from rabbit back muscle in a volume of 25 ml
(buffer A plus 1 mM ATP), and centrifuged again at 361,000 g for 1
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from the actin filaments by incubation in buffer A plus 1 M KCl,
followed by centrifugation at 361,000 g for 1 hour. These actin-
binding proteins (100 m g protein per injection) provided the antigen
used for subcutaneous injection of Balb/c mice. Eye bleeds were taken
after the second and third injections. Sera were screened using western
blots of the antigen. A mouse with reactive sera (including reaction
with a 115 kDa polypeptide) was used to make monoclonal antibodies
by conventional procedure. The spleen of the mouse was removed,
teased apart and the cells rinsed in RPMI 1640 medium. Mouse
myeloma cell line (P3 X 63AG88653) was fused with the spleen cells
in 50% polyethylene glycol. The cells were rinsed in medium and
plated at limiting dilution in microtitre plates with mouse peritoneal
feeder cells. One clone recognized a 115 kDa polypeptide, and was
used to initiate the present study.
Polyclonal antibodies were made against the 115 kDa polypeptide,
which was identified as OS guanylate cyclase. Antibodies were made
against the whole polypeptide, which was purified in denatured form
by washing the Triton X-100-insoluble fraction (prepared as above)
two times with 10 M urea, pH 7. The resulting urea pellet was
separated by SDS-PAGE and the polypeptide recognized by the mon-
oclonal antibody was cut out of a Coomassie-blue stained gel. The gel
was pulverized between two glass plates and injected (100 m g protein
per injection) with adjuvant subcutaneously into the backs of Long
Evans rats or New Zealand white rabbits.
Polyclonal antibodies were also made against a peptide corre-
sponding to the last 10 amino acids of the bovine OS guanylate
cyclase that appears to be the homologue of human RetGC-1 (Goracz-
niak et al., 1994). The peptide was synthesized as a multiple antigen
peptide, or MAP (Tam, 1988), by the Indiana University School of
Medicine (Indianapolis) Biochemistry Biotechnology Facility. The
MAP was used as an immunogen to generate antisera in rats (as
above) or in rabbits (standard protocol by Biosynthesis, Texas).
The polyclonal antibodies were affinity-purified by the method of
Olmsted (1986). Briefly, a blot of antigen (isolated guanylate
cyclase or MAP) on Immobilon-P was blocked with 5% non-fat dry
milk and 3% BSA in Tris-buffered saline (TBS). Antiserum that was
about 100 times more concentrated than that needed to detect the
enzyme on the blot was incubated overnight with the Immobilon.
The Immobilon was then rinsed with TBS and the antibody was
eluted with 200 mM glycine, pH 2.5. The pH was immediately neu-
tralized with Tris base.
For immunolabelling of western blots and retinal sections by the
polyclonal antibodies, negative control tests were routinely
performed. Before use as a negative control, the affinity-purified
antibody was incubated with a narrow strip of Immobilon-P, cut hor-
izontally from western blots of heavily-loaded OS urea pellet or dark-
adapted OS Triton X-114 soluble fraction, so as to include polypep-
tides only with an apparent molecular mass of around 115 kDa.
Alternatively, in the case of the peptide antibodies, the antibody was
mixed with 0.1 mg/ml peptide in solution. 
A sample of polyclonal antibody against guanylate cyclase that had
been purified to homogeneity by column chromatography from bovine
OSs was given to us by Dr Karl Koch (Koch, 1991). This antibody
was used to label western blots for comparison with our antibodies.
A monoclonal antibody against the C terminus of rat peripherin/rds
was a gift from Dr Bob Molday and used as in Arikawa et al. (1992).
Immunolabelling western blots
Proteins were separated by SDS-PAGE and transblotted at 4°C onto
Immobilon-P (Millipore) in 25 mM Tris-HCl, 192 mM glycine, and
20% (v/v) MeOH, for 5 hours at 90 V or overnight at 40 V. The
membrane was blocked overnight with blocking buffer: 5% nonfat
dry milk, 3% bovine serum albumin, and 0.05% sodium azide, in TBS
(8 g/l NaCl, 0.2 g/l KCl, Tris-HCl, pH 7.5) and incubated with
antibody for 2-16 hours. The blot was rinsed 4· 15 minutes in TBS,
incubated with secondary antibody conjugated to alkaline phos-phatase for 2 hours, and rinsed again. Color development was with
NBT-BCIP. 
Peptide sequencing 
The same polypeptide from the OS urea pellet that was used as an
immunogen (above) was transblotted on to Immobilon-P. It was sent
to the Harvard Microchemistry Facility (Harvard University,
Cambridge, MA). Under the supervision of Bill Lane, it was digested
in situ with Lys-C and the resulting peptides separated by high
pressure liquid chromatography. The sequences of the peptides in
three of the major peaks were determined by Edman degradation.
Actin blot overlays
This protocol detects actin binding proteins by overlaying transblot-
ted proteins with actin filaments, and then detecting where the actin
filaments have bound by immunolabelling with an actin antibody.
This protocol is a modified version of that described by Walker et al.
(1984), who used it to test the actin binding ability of the acetylcholine
receptor. Proteins were separated by SDS-PAGE and transferred to
Immobilon-P. Many, though not all, proteins appear to renature and
thus retain their binding properties after transfer to nitrocellulose or
Immobilon (Carr and Scott, 1992). The membrane was blocked by
incubation for 3-24 hours with 5% non-fat dry milk and 3% BSA in
TBS. It was then incubated overnight in blot overlay buffer: 20 mM
Tris-HCl, pH 7.5, 130 mM KCl, 20 mM NaCl, 10 mM MgCl2, 0.2
mM CaCl2, 0.2 mM ATP, 1 mg/ml BSA, 10 m g/ml phalloidin and 10
m g/ml actin filaments. The actin filaments were prepared from rabbit
back skeletal muscle, as described by Pardee and Spudich (1982).
After rinsing in TBS for 3 · 15 minutes, the blot was air dried for 4-
6 hours. The blot was made wet again by brief immersion in ethanol,
and then washed with TBS. It was incubated overnight with a mono-
clonal antibody against actin (made by Lin (1981), and provided by
the Developmental Studies Hybridoma Bank), which was in turn
detected with an alkaline phosphatase-conjugated secondary
antibody. The color development was with nitro blue tetrazolium and
5-bromo-4-chloro-3-indoylphosphate. 
Guanylate cyclase activity assays
Guanylate cyclase activity was measured in the Triton X-100-
insoluble fraction or the Triton X-114-soluble fraction of dark-
adapted bovine OSs, in the presence of different amounts of added
actin filaments (from rabbit skeletal muscle, as above). To remove as
much of the endogenous filamentous actin as possible from the Triton
X-100-insoluble fraction, we incubated the fraction with low salt
buffer, 20 mM Tris-HCl, pH 8, 0.5 mM EGTA, 0.5 mM DTT, for 30
minute at 37°C, and, after centrifugation, discarded the supernatant
(cf. Pardee and Spudich, 1982). The proteins were suspended in buffer
B, 20 mM Tris-HCl, pH 8, 1 mM DTT 10 m g/ml phalloidin, and 0.1%
Lubrol (ICN Biochemicals). The reaction was started by adding 2 mM
MnCl2, 2 mM GTP and 1 m Ci [3H]GTP (New England Nuclear) in a
final volume of 25 m l. After incubation at 30°C, the reaction was
stopped by adding EGTA, to give a concentration of 10 mM, and
heating at 90°C for 5 minutes. The nucleotides were separated on PEI-
F-cellulose thin-layer chromatography (TLC) plates (Baker-flex)
(Kavipurapu et al., 1982). A 1 m l sample of each reaction was spotted
on the TLC plate 3 cm from the bottom. After drying, 1 m l of a
nucleotide mix, 25 mM each of GTP, GDP, GMP and cGMP, was
added to the same spot and allowed to dry. The plate was developed
with 600 mM LiCl for half the distance and 1 M LiCl for the
remainder. When the solvent reached the top, 17 cm from the origin,
the plate was viewed under long wavelength UV light. Nucleotides
were seen as dark spots on a fluorescent background. Spots were cut
out and counted in a scintillation counter. As the Triton X-100-
insoluble fraction contained insignificant phosphodiesterase activity,
phosphodiesterase inhibitors were unnecessary. For assaying
guanylate cyclase activity in the Triton X-114 soluble fraction, we
followed the procedure of Gorczyca et al. (1994). In this procedure
1805Distribution of OS guanylate cyclase(Sp)GTP was used as a substrate, for the product, (Rp)cGMP, is not
hydrolyzed by PDE.
A partially-pure fraction containing bovine GCAP-1 was given to
us by Dr Alexander Dizhoor in Dr James Hurley’s laboratory.
Immunomicroscopy
Guanylate cyclase was localized in sections of rat retinas. The
advantage of using rat retinas, in contrast to bovine retinas, was that
the animals could be maintained in a controlled light environment and
that the retinas could be fixed immediately upon death. Long Evans
rats were maintained on a 12 hour light/12 hour dark cycle. Dark
adapted retinas were obtained 4 hours after lights-off, and light-
adapted retinas were obtained 4 hours after lights-on. Retinas were
also obtained from animals that had been exposed to 5 minutes of light
4 hours after lights-off, or placed in darkness for 5 minutes 4 hours
after lights-on. The posterior segments of each eye were processed as
described by Williams et al. (1990). Briefly, they were fixed in 4%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for light
microscopy. For electron microscopy, the fixative contained 0.1-1%
glutaraldehyde plus 2% paraformaldehyde. Thick (7-10 m m) cryosec-
tions were prepared from OCT-embedded tissue, semithin (0.5 m m)
cryosections were prepared from sucrose-embedded tissue, and
ultrathin sections were prepared from LR White-embedded tissue.
Some cryosections were extracted briefly with detergent by incubat-
ing them for 5-10 minutes in buffer containing 0.5% Triton X-100,
50 mM NaCl, 3 mM MgCl2, 200 mM sucrose, 10 mM Hepes, pH 7.4.
The sections were blocked with 3% BSA in PBS, incubated with
diluted primary antibodies in 1-3% BSA in PBS overnight, washed
3· 10 minutes in PBS, incubated with the appropriate secondary
antibody conjugated to Texas Red (for immunofluorescence) or
colloidal gold (for electron microscopy), and washed again with PBS.washed twice more (TP, lanes 3 and 9), and then extracted with 6 M urea
washed two more times (lanes 5 and 11). Lane 6 shows molecular mass 
immunolabelled with the antibody used in B (lane 1) and an antibody tha
by Dr Karl Koch (lane 2). The proteins were separated in a single lane on
give lanes 1 and 2.In some cases, sequential sections were labelled with the different
guanylate cyclase antibodies or with a guanylate cyclase antibody and
anti-peripherin/rds, so that labelling patterns could be more readily
compared.
RESULTS
Antibodies against OS guanylate cyclase
Using a mixture of bovine OS actin-binding proteins as an
immunogen, we isolated a hybridoma cell line producing an
antibody that recognized a 115 kDa polypeptide on western
blots of bovine OS proteins (Fig. 1A, lane 2). The antibody
also recognized a polypeptide with slightly greater mobility in
rat OSs (Fig. 1A, lane 1). Although the immunogen was
prepared from a high salt extract of the detergent-insoluble
fraction of OSs (followed by desalting and binding to actin
filaments), the recognized 115 kDa polypeptide was actually
more enriched in the fraction that remained insoluble after
bovine OSs had been washed in buffer containing 2% Triton
X-100, and then buffer containing 6 M urea (lane 5, Fig. 1B).
The polypeptide was purified from this urea-insoluble fraction
and used to generate a polyclonal antibody, which showed
greater specificity than the monoclonal antibody. The 115 kDa
polypeptide recognized by the antibodies appeared to be
guanylate cyclase, based on two criteria. Firstly, its labelling
on western blots of various OS fractions by our antibodies and
an antibody from Dr K. Koch, which was made against
guanylate cyclase purified by column chromatography fromFig. 1. OS guanylate cyclase
(115 kDa polypeptide) in
different OS fractions and its
detection by different antibodies.
(A) Western blot of Triton X-
100-insoluble fraction of rat
(lane 1) and bovine (lane 2)
OSs, immunolabelled with
monoclonal antibody. Relative
positions of same molecular
mass standards as in lane 6, part
B, are indicated on the right.
(B) Coomassie blue-stained gel
(lanes 1-6) and western blot
(lanes 7-11) of different
fractions of dark-adapted bovine
OSs. The western blot was
immunolabelled with affinity-
purified polyclonal antibody
generated against urea-insoluble
guanylate cyclase. OSs were
homogenized in buffer A to
yield the cytosolic fraction (C,
lanes 1 and 7). The membrane
pellet was washed twice more
and then extracted with buffer A
plus 3% Triton X-100 to yield
lanes 2 and 8 (TS). The
detergent-insoluble fraction was
, pH 7, to yield lanes 4 and 10 (US). The urea pellet (UP) was then
standards (in kDa). (C) Western blot of bovine OS proteins
t was made against homogeneous guanylate cyclase from bovine OSs
 a gel. The lane was then cut in half lengthwise after transblotting to
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Fig. 2. Domain structure of guanylate
cyclase, illustrating the regions to
which the sequenced peptides we
obtained from the bovine OS 115 kDa
polypeptide correspond (cf.
Goraczniak et al., 1994). Amino acid
sequences were determined from three
peptides released by Lys-C digestion
of the polypetide. Designation of
lysine as the first amino acid of each
peptide follows from the use of Lys-C
to generate the peptides. The identity
of the other amino acids was
determined from Edman degradation.
X indicates that the identity of the
amino acid was not clear. For
comparison, the corresponding
sequences of human RetGC-1 and RetGC-2 and rat GC-E and GC-F are shown below the bovine peptide sequences we obtained. Amino acid
numbers refer to bovine sequence (Goraczniak et al., 1994). Alignment of bovine OS guanylate cyclase with human RetGC-1 from Goraczniak
et al. (1994); alignment of human RetGC-2 with human RetGC-1 from Lowe et al. (1995); corresponding sequences of rat GC-E and GC-F
were obtained from Yang et al. (1995). Dashes indicate no corresponding residues with these alignments (the bovine sequence and rat GC-E
contain two additional amino acids at their C termini).
Extracellular Intracellular
Transmembrane
CN
Bovine 
RetGC-1
GC-E
RetGC-2
GC-F
1043-1052
KARPGQFSGK
KARPGQFS--
KARPGQFTGK
RQLVRNKP--
RQLVRNKP--
    471-485
KVXQGSRTSLAARSI
KVAQGSRSSLGARSM
KVAQGSRSSLATRST
----GSRASVSFQIT
----GSRASVSFQII
      797-815
KTDRLLTQMLPPSVAEALK
KTDRLLTQMLPPSVAEALK
KTDRLLTQMLPPSVAEALK
KTEKLLTQMLPPSVAESLK
KTEKLLTQMLPPSVAESLK
Fig. 3. Western blots of rat
retinal proteins immunolabelled
with affinity-purified antibodies
against bovine OS guanylate
cyclase; these antibodies were
used for immunolabelling of rat
retinal sections. (A) Test for
specific labelling of guanylate
cyclase. Lane 1, polyclonal
antibody against whole protein.
Lane 2, as for lane 1, except
antibody was preincubated with
guanylate cyclase on
Immobilon-P. Lane 3, antibody
made in rat against C-terminal
peptide. Lane 4, as for lane 3,
except that 0.1 mg/ml C-
terminal peptide was included
with antibody. Positions of
molecular mass standards (kDa)
and dye front (F) are indicated
on left. (B) Comparison of
labelling by the two antibodies.
Lane 1, polyclonal antibody
against whole protein. Lane 3,
antibody made against C-
terminal peptide. Lane 2, both
antibodies mixed 50:50. A single band is evident in all lanes,
including lane 2. The same result was found with western blots of
bovine OS proteins. In B, the western blot was not cut into strips.
Instead separate lanes were effected by creating isolated channels on
the blot surface with a plexiglass clamp apparatus; the different
antibodies and the washing solutions were pipetted into these
channels.
Fig. 4. Western blot of dark- and
light-adapted bovine OSs
solubilized in buffer containing
Triton X-114, and then centrifuged
at high speed. The blot was labelled
with anti-guanylate cyclase. Lanes 1
and 2 contain the soluble proteins
from light- and dark-adapted OSs,
respectively. Lanes 3 and 4 contain
the insoluble proteins from light-
and dark-adapted OSs, respectively.bovine OSs (Koch, 1991), was the same (Fig. 1C). Secondly,
partial sequence data, obtained from the immunogen used to
generate the polyclonal antibody, corresponded to regions of
the sequence of the bovine retinal guanylate cyclase, cloned
and described by Goraczniak et al. (1994) (Fig. 2). This bovine
enzyme appears to be the homologue of RetGC-1 in humanretina (Shyjan et al., 1992) and GC-E in rat retina (Yang et al.,
1995) (Fig. 2). 
Additional antisera were raised successfully against the
bovine C-terminal peptide shown in Fig. 2. Resulting affinity-
purified peptide antibodies immunolabelled western blots of
different bovine OS fractions in the same manner as the poly-
clonal antibody against the whole protein (cf. Fig. 1B, lanes 7-
11), providing further evidence that the latter recognizes
guanylate cyclase. 
The antibody against the whole protein and one of the anti-
bodies against the C-terminal peptide were found to be most
suitable for labelling sections of rat retinas (see below). These
affinity-purified antibodies reacted specifically with a single
polypeptide on western blots of rat OSs (Fig. 3A). Both
labelled the same polypeptide (Fig. 3B). Examination of the C-
terminal sequences of the two retinal guanylate cyclases (Fig.
2), indicates that this recognized polypeptide is the RetGC-
1/GC-E form of guanylate cyclase (which we will call RetGC-
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Fig. 5. Actin blot overlay of Triton X-100-
insoluble fraction of bovine OSs. Lane 1,
SDS-PAGE of molecular mass standards
stained with Coomassie blue. Lanes 2-4
each contain the same amount of detergent-
insoluble OS proteins. Lane 2, SDS-PAGE
stained with Coomassie blue. Lane 3,
western blot overlaid with actin filaments.
Bound filaments were detected with anti-
actin; the intensely labelled protein
comigrating with the 45 kDa marker is
endogenous actin. Lane 4, western blot
immunolabelled with anti-guanylate
cyclase. 
Fig. 7. Immunofluorescence of 0.5 m m cryosection of rat retina,
labelled with anti-guanylate cyclase. Prior to labelling the section
was incubated briefly in buffer containing 0.5% Triton X-100.
Retinal pigmented epithelium (RPE), outer segments (OS), inner
segments (IS), outer limiting membrane (OLM), outer nuclear layer
(ONL), outer plexiform layer (OPL), inner nuclear layer (INL), inner
plexiform layer (IPL). Bar, 20 m m.1; cf. Lowe et al., 1995; Yang et al., 1995). RetGC-2 migrates
slightly faster than RetGC-1 in SDS-PAGE (Lowe et al.,
1995).
Detergent insolubility
In early studies it was found that nearly all of the OS guanylate
cyclase activity was associated with a detergent-insoluble
fraction, which consisted mainly of OS axonemes (Krishnan et
al., 1978; Fleischmann and Denisevich, 1979; Fleischmann et
al., 1980). As illustrated in Fig. 1B, our studies also show that
most of the enzyme is insoluble, even in urea. Nevertheless,
protocols have now been designed for the chromatographic
purification of OS guanylate cyclase, in which washing the OS
cytoskeleton with buffer containing a combination of detergent
and high salt concentration, such as 5% (v/v) dodecyl-b -D-
maltoside and 1 M KCl, results in extraction of a portion of
the enzyme activity (Hayashi and Yamazaki, 1991; Koch,
1991). Most recently, guanylate cyclase was obtained after sol-
ubilization of OS membranes in 1.5% dodecyl-b -D-maltoside
and 50 mM NaCl (Aparicio and Applebury, 1995). We foundFig. 6. Guanylate cyclase activity in the Triton X-100-insoluble
fraction of bovine OSs, measured as a function of added filamentous
actin. Activity is shown as a percentage of that without additional
actin filaments.
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ol)that homogenization of dark-adapted bovine OSs in ice-cold
buffer containing 3% Triton X-114 and 100 mM KCl resulted
in solubilization of most of the guanylate cyclase. Interestingly,
if the OSs were first exposed to 10 minutes of light, the
guanylate cyclase was mostly insoluble (Fig. 4), indicating that
light exposure affects the partitioning of the enzyme with the
OS cytoskeleton.
Binding to actin filaments
Because we had obtained a monoclonal antibody against
guanylate cyclase using OS actin-binding proteins as the
immunogen, it seemed that the enzyme might associate with
the OS cytoskeleton as a result of binding to actin filaments.
To test if OS guanylate cyclase could bind directly to actin
filaments, we performed ‘actin blot overlays’ with insoluble
OS fractions. Western blots containing proteins of these
fractions were incubated with actin filaments, and the proteins
that bound the actin filaments were identified by immunola-
belling the blots with actin antibodies. One of the identified
actin binding proteins has the same mobility as guanylate
cyclase (Fig. 5), suggesting that the enzyme can bind directly
to actin filaments. Guanylate cyclase from both light- and dark-
adapted OSs appeared to bind actin filaments to the same
extent.
To see if any effect of actin filaments on guanylate cyclase
activity could be detected, we measured the activity of the
Triton X-100-insoluble OS fraction, in the presence of
different concentrations of actin filaments. Although the
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Fig. 8. Immunofluorescence of 0.5 m m cryosection of rat retina,
labelled with anti-guanylate cyclase. ROSs are shown in oblique
section and are labelled throughout. Same magnification as Fig. 9.
Fig. 9. Immunofluorescence of 0.5 m m cryosection of rat retina,
labelled with anti-peripherin/rds. ROSs are shown in oblique section
and are labelled only around their periphery. Bar, 10 m m.
Fig. 10. Electron micrograph of an ultrathin section of rat retina,
immunogold labelled by anti-guanylate cyclase that had been
preincubated with Immobilon containing purified guanylate cyclase.
This control section was labelled in parallel with those shown in Figs
11 and 12. Significant label is not evident over any structure. Same
magnification as Fig. 12.fraction was washed first with low salt buffer to extract
endogenous actin (cf. Pardee and Spudich, 1982; Pinder and
Gratzer, 1983), a significant portion could not be extracted,
resulting in about 1 m g/ml endogenous actin in all samples
assayed. The addition of up to 100 m g/ml filamentous actin had
no effect on guanylate cyclase activity (Fig. 6). The same
negative result was found irrespective of whether light- or
dark-adapted OSs were used. Similarly, we did not detect any
effect of 100 m g/ml filamentous actin on guanylate cyclase
activity in a Triton X-114-soluble fraction of dark-adapted
OSs. The urea-insoluble fraction could not be used for these
tests as exposure to urea abolished guanylate cyclase activity.
In both the Triton X-100-insoluble fraction and the Triton X-
114-soluble fraction, we measured basal guanylate cyclase
activity. Guanylate cyclase activity in OS membranes is
enhanced greatly by the addition of guanylate cyclase activat-
ing protein (GCAP) in low Ca2+ concentrations (Dizhoor et al.,
1994). We therefore attempted to test the ability of partially-
pure bovine GCAP-1 to activate guanylate cyclase in the Triton
X-100-insoluble OS fraction and in the Triton X-114-soluble
OS fraction. Despite being able to activate guanylate cyclase
in OS membranes that had been extensively washed in low
ionic strength buffer, this GCAP-1 preparation had no effecton guanylate cyclase activity in these detergent-treated
fractions, so that we were unable to test for any effect of actin
filaments on GCAP-stimulated guanylate cyclase activity.
Immunomicroscopic localization of guanylate
cyclase
Affinity-purified polyclonal antibodies against the whole
protein and against the C-terminal peptide were used to
localize the RetGC-1 homologue of guanylate cyclase in retinal
sections. Rat retinas (in contrast to bovine retinas) were used
for these immunomicroscopical studies as they could be fixed
under controlled lighting and circadian conditions. By
immunofluorescence microscopy of thick (7 m m) and semithin
(0.5 m m) cryosections, guanylate cyclase was detected only in
the OS layer (Fig. 7), which in rats consists of nearly all rod
photoreceptor outer segments (ROSs). Both antibodies gave
the same labelling pattern. No difference was detected between
the labelling of light- and dark-adapted retinas. Prior incuba-
tion of the antibodies with isolated guanylate cyclase (on
western blots), or, in the case of the peptide antibodies, with
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Fig. 11. Electron micrograph of an ultrathin section of rat retina, immunogold labelled by anti-guanylate cyclase. Label is evident over all the
disk membranes of the rod outer segments (OS), but is absent from the connecting cilium (C) and the inner segment (IS). Same magnification
as Fig. 12.
Fig. 12. Electron micrograph of an ultrathin section of rat retina, immunogold labelled by anti-peripherin/rds. Label is restricted to the margins
of the disk membranes of the ROSs. Label is more widespread on one side of each ROS probably because of labelling of an incisure (cf.
Molday et al., 1987). Bar, 0.5 m m.0.1 mg/ml peptide, abolished the labelling. In sections that
were incubated with buffer containing 0.5% Triton X-100 for
5-10 minutes before the addition of the antibody, labelling
appeared to be greater along the margins of the ROSs (note
streaky appearance of label in Fig. 7). To determine if
guanylate cyclase might be distributed preferentially at the
periphery of the ROSs (perhaps restricted to the plasma
membrane), we compared the immunolabelling of guanylate
cyclase and peripherin/rds in oblique sections of the outer
segments that had not been pretreated with detergent. Periph-
erin/rds is located in the disk rims (Molday et al., 1987;
Arikawa et al., 1992). As can be seen by comparing Figs 8 and
9, the entire ROS profile is filled by guanylate cyclase label,
whereas the peripherin/rds labelling pattern of each ROS
appears like an annulus, with the central part unlabelled.
The same affinity-purified antibodies were used for
immunogold labelling of ultrathin sections (Figs 10 and 11).
By electron microscopy label was found over the entire ROS
section, with the exception of the connecting cilium. Consis-
tent with the immunofluorescence images of thicker sections,the inner segment was also not labelled (Fig. 11). Although the
intensity of the gold label was not as great as we have encoun-
tered with antibodies against a number of other ROS proteins,
it appeared to be specific, for sections exposed to antibody that
had been preincubated with immunoblotted guanylate cyclase
were not labelled (Fig. 10). Moreover, the guanylate cyclase
labelling pattern of the ROS disks contrasted with periph-
erin/rds labelling. Fig. 12 shows an electron micrograph of
ROSs labelled anti-peripherin/rds. The section was from the
same block as the sections in Figs 10 and 11, and the three
were labelled in parallel. However, peripherin/rds label is
limited to the margins of each ROS.
DISCUSSION
Guanylate cyclase activity has been found previously to
partition with the OS cytoskeleton (Krishnan et al., 1978;
Fleischmann and Denisevich, 1979; Fleischmann et al., 1980).
In the present study, we have used antibodies to detect the
1810 M. A. Hallett and othersbovine and rat homologues of RetGC-1, which is one of two
transmembrane guanylate cyclases found in human photo-
receptor cells (Lowe et al., 1995). Consistent with the earlier
studies, we observed by western blot analysis that this enzyme
partitioned with the OS cytoskeleton. In addition, we noted that
this partitioning was affected by light. Horio and Murad (1991)
had observed that less guanylate cyclase activity was extracted
by 1 M KCl plus Triton X-100 or Lubrol PX if the OSs were
bleached. We also found that the enzyme can bind directly to
actin filaments. As actin filaments form part of the OS
cytoskeleton, this binding suggests a mechanism for the asso-
ciation of the enzyme with the cytoskeleton. Nevertheless, it
cannot account for its insolubility in urea, for urea extracts
actin filaments. Here insolubility is most likely due to aggre-
gation of denatured enzyme; enzyme activity was destroyed by
urea. 
The ability of OS guanylate cyclase to bind actin filaments
may have physiological consequences. It could be important
for docking the enzyme or influencing its activity. An example
of another transmembrane enzyme that has been reported to
bind actin filaments is the EGF receptor (Hartigh et al., 1992).
It is estimated that only 5% of this receptor is bound, but that
which is bound has a higher affinity for EGF (Van Bergen en
Henegouwen et al., 1989; Wiegant et al., 1986). Our studies
found that actin filaments had no effect on basal guanylate
cyclase activity, but the possibility of an effect on GCAP-stim-
ulated activity remains to be tested. 
There have been two previous reports on the immuno-
localization of guanylate cyclase in retinas, both using
primate retinas. Dizhoor et al. (1994) described immuno-
fluorescence of thick retinal sections, and showed that
RetGC-1 was in the outer segments, and possibly the inner
segments of human photoreceptor cells. Liu et al. (1994)
reported results from electron immunomicroscopy of monkey
and human retinas. Both groups found labelling of RetGC-1
in both cone and rod photoreceptor cells, with more intense
labelling in cones. In the present study, we investigated the
localization of this enzyme in the rat retina, which contains
very few cone cells, so that we have not addressed any dif-
ferences between rods and cones. 
Focusing on the subcellular localization within the rod pho-
toreceptor cells, we find that our results are not entirely con-
sistent with those of Liu et al. (1994). We agree in that the con-
necting cilium was not labelled, but disagree in two other
respects. Firstly, Liu et al. show immunolabelling in the inner
segments as well as the outer segments, whereas all of our anti-
bodies labelled only the outer segments. Secondly, they
reported greater labelling at the periphery of the outer
segments. RetGCs belong to the guanylate cyclase membrane
receptor family (Shyjan et al., 1992; Lowe et al., 1995). Such
guanylate cyclases have an intracellular protein kinase-like
domain and cyclase catalytic domain, a single transmembrane
domain, and an extracellular ligand-binding domain (Garbers
and Lowe, 1994). Although no extracellular ligand has yet
been defined for RetGCs, if they were regulated by one, like
the other members of the family, they might be expected to be
restricted to the plasma membrane of the ROS, which would
effect a peripheral labelling pattern. In our hands, the periphery
of the ROSs retained more immunoreactive guanylate cyclase
after detergent treatment, but without detergent extraction, the
enzyme was found throughout the outer segment, in contrastto peripherin/rds. Therefore, our results indicate that RetGC-1
is localized throughout the disk membranes. Retention of
guanylate cyclase in the periphery after detergent extraction
might be due to association of the enzyme in the disk rim or
plasma membrane with the cytoskeleton, or association of the
enzyme in the plasma membrane with insoluble components
of the extracellular matrix. Given that the protein composition
of the ROS plasma membrane and the ROS disk membranes
are quite different (Molday and Molday, 1987), it is plausible,
however, that RetGC-1 might be absent from the plasma
membrane (immunoelectron microscopy of tissue sections
does not provide sufficient resolution to determine if this is
true).
It is unclear why our results differ from those of Liu et al.
(1994). It could be due to inherent differences between primate
photoreceptors and those of rats. It is worth noting, however,
that we found the same labelling with an antibody against the
whole protein as well as an antibody against a C-terminal
peptide; the results of Liu et al. were obtained with a single
peptide antibody. Moreover, we were able to assess the
question of peripheral outer segment distribution by comparing
the labelling with that of peripherin/rds, which is known to be
located only in the disk rims and thus provides a positive
control for peripheral labelling.
What is the functional significance of the distribution of
guanylate cyclase throughout the ROS disk membranes, rather
than around the periphery of the ROS? The answer to this
question should become clearer with further studies on the bio-
chemical regulation of guanylate cyclase. Perhaps it is
pertinent that localization of guanylate cyclase in the ROS disk
membranes more closely coincides with the distribution of the
GCAPs, which are soluble proteins concentrated in the OSs
(Dizhoor et al., 1995; Gorczyca et al., 1994, 1995). A conse-
quence of this guanylate cyclase localization is that it places
the extracellular domain of the enzyme in the intradiskal space,
where it cannot be exposed to extracellular ligands.
The immunolocalization of guanylate cyclase appears
difficult to reconcile with its actin-binding property and the
reported distribution of actin filaments. A domain of actin
filaments has been described in the connecting cilium between
the inner and outer segment (see Williams, 1991, for review).
Ironically, this was the one domain of the outer segment that
was not labelled by guanylate cyclase antibodies. It is of course
possible that immunoreactive sites are masked in this region
(perhaps due to actin binding). Note that even opsin, the major
protein of ROS disk and plasma membranes, is often immuno-
labelled poorly or not at all in the plasma membrane of the con-
necting cilium (cf. Nir and Papermaster, 1983; Nir et al., 1984;
Besharse et al., 1985; Hicks and Molday, 1986; Usukura and
Bok, 1987; Röhlich et al., 1989), possibly as a result of epitope
masking in this region (Besharse et al., 1985; Bok, 1985;
Miyaguchi and Hashimoto, 1992). Likewise, in our studies of
peripherin/rds, including the present one, peripherin/rds
labelling was not detectable in the connecting cilium (Fig. 12).
A second possibility is that actin filaments are present
elsewhere in the outer segment, but have yet to be detected.
The procedures used to visualize the spectrin-actin cytoskele-
ton underlying the erythrocyte plasma membrane (Byers and
Branton, 1985; Liu et al., 1987; Derick et al., 1992), for
example, have not been applied to ROSs. Interestingly,
detergent-extraction of retinal sections resulted in selective
1811Distribution of OS guanylate cyclaseretention of guanylate cyclase near the outer segment plasma
membrane, which would be consistent with binding of
guanylate cyclase to the cytoskeleton in this region. 
In conclusion, the guanylate cyclase, RetGC-1, partitions
with the OS cytoskeleton in a light-sensitive manner, possibly
due to its ability to bind actin filaments. The enzyme is
restricted solely to the outer segment, where it is distributed
throughout the disk membranes. 
We are grateful to Dr Karl Koch for a sample of his guanylate
cyclase antibody, Drs Sasha Dizhoor and Jim Hurley for the GCAP
fraction, Dr Bob Molday for the peripherin/rds antibody, and the
Developmental Studies Hybridoma Bank (supported by NIH contract
N01-HD-6-2915) for the actin antibody. The work was supported by
NIH grant EY 07042 to D.S.W.
REFERENCES
Aparicio, J. G. and Applebury, M. L. (1995). The bovine photoreceptor outer
segment guanylate cyclase: purification, kinetic properties, and molecular
size. Prot. Express. Purif. 6, 501-511.
Arikawa, K., Molday, L. L., Molday, R. S. and Williams, D. S. (1992).
Localization of peripherin/rds in the disk membranes of cone and rod
photoreceptors: relationship to disk membrane morphogenesis and retinal
degeneration. J. Cell Biol. 116, 659-667.
Azarian, S. M., King, A. J., Hallett, M. A. and Williams, D. S. (1995).
Selective proteolysis of arrestin by calpain: molecular characterization and
its effect on rhodopsin dephosphorylation. J. Biol. Chem. 270, 24375-24384.
Besharse, J. C., Forestner, D. M. and Defoe, D. M. (1985). Membrane
assembly in retinal photoreceptors. III. Distinct membrane domains of the
connecting cilium of developing rods. J. Neurosci. 5, 1035-1048.
Bok, D. (1985). Retinal photoreceptor-pigment epithelium interactions. Invest.
Ophthalmol. Vis. Sci. 26, 1659-1694.
Byers, T. J. and Branton, D. (1985). Visualization of the protein associations
in the erythrocyte membrane skeleton. Proc. Nat. Acad. Sci. USA 82, 6153-
6157.
Carr, D. W. and Scott, J. D. (1992). Blotting and band-shifting: techniques for
studying protein-protein interactions. Trends Biochem Sci. 17, 246-249.
Derick, L. H., Liu, S., Chishti, A. H. and Palek, J. (1992). Protein
immunolocalization in the spread erythrocyte. Eur. J. Cell Biol. 57, 317-320.
Dizhoor, A. M., Lowe, D. G., Olshevskaya, E. V., Laura, R. P. and Hurley,
J. B. (1994). The human photoreceptor membrane guanylyl cyclase, RetGC,
is present in outer segments and is regulated by calcium and a soluble
activator. Neuron 12, 1345-1352.
Dizhoor, A. M., Olshevskaya, E. V., Henzel, W. J., Wong, S. C., Stults, J. T.,
Ankoudinova, I. and Hurley, J. B. (1995). Cloning, sequencing, and
expression of a 24 kDa Ca plus-binding protein activating photoreceptor
guanylyl cyclase. J. Biol. Chem. 270, 25200-25206.
Fleischman, D. and Denisevich, M. (1979). Guanylate cyclase of isolated
bovine retinal rod axonemes. Biochemistry 18, 5060-5066.
Fleischman, D., Denisevich, M., Raveed, D. and Pannbacker, R. G. (1980).
Association of guanylate cyclase with the axoneme of retinal rods. Biochim.
Biophys. Acta 630, 176-186.
Garbers, D. L. and Lowe, D. G. (1994). Guanylyl cyclase receptors. J. Biol.
Chem. 269, 30741-30744.
Goraczniak, R. M., Duda, T., Sitaramayya, A. and Sharma, R. K. (1994).
Structural and functional characterization of the rod outer segment
membrane guanylate cyclase. Biochem. J. 302, 455-461.
Gorczyca, W. A., Gray-Keller, M. P., Detwiler, P. B. and Palczewski, K.
(1994). Purification and physiological evaluations of a guanylate cyclase
activating protein from retinal rods. Proc. Nat. Acad. Sci. USA 91, 4014-
4018.
Gorczyca, W. A., Polans, A. S., Surgucheva, I. G., Subbaraya, I., Baehr, W.
and Palczewski, K. (1995). Guanylyl cyclase activating protein. J. Biol.
Chem. 270, 22029-22036.
Hakki, S. and Sitaramayya, A. (1990). Guanylate cyclase from bovine rod
outer segments: Solubilization, partial purification, and regulation by
inorganic pyrophosphate. Biochemistry 29, 1088-1094.
Hartigh, J. C., van Bergen en Henegouwen, P. M. P., Verkleij, A. J. and
Boonstra, J. (1992). The EGF receptor is an actin-binding protein. J. Cell
Biol. 119, 349-355.Hayashi, F. and Yamazaki, A. (1991). Polymorphism in purified guanylate
cyclase from vertebrate rod photoreceptors. Proc. Nat. Acad. Sci. USA 88,
4746-4750.
Hicks, D. and Molday, R. S. (1986). Differential immunogold-dextran
labeling of bovine and frog rod and cone cells using monoclonal antibodies
against bovine rhodopsin. Exp. Eye Res. 42, 55-71.
Horio, Y. and Murad, F. (1991). Solubilization of guanylyl cyclase from
bovine rod outer segments and effects of lowering Ca2+ and nitro
compounds. J. Biol. Chem. 266, 3411-3415.
Kavipurapu, P., Farber, D. and Lolley, R. (1982). Degradation and
resynthesis of cyclic 3¢ ,5¢ -guanosine monophosphate in truncated rod
photoreceptors from bovine retina. Exp. Eye Res. 34, 181-189.
Koch, K.-W. and Stryer, L. (1988). Highly cooperative feedback control of
retinal rod guanylate cyclase by calcium ions. Nature 344, 64-66.
Koch, K.-W. (1991). Purification and identification of photoreceptor guanylate
cyclase. J. Biol. Chem. 266, 8634-8637.
Krishnan, N., Fletcher, R. T., Chader, G. J. and Krishna, G. (1978).
Characterization of guanylate cyclase of rod outer segments of the bovine
retina. Biochim. Biophys. Acta 523, 506-515.
Lagnado, L. and Baylor, D. (1992). Signal flow in visual transduction. Neuron
8, 995-1002.
Lin, J. J. C. (1981). Monoclonal antibodies against myofibrillar components of
rat skeletal muscle decorate the intermediate filaments of cultured cells.
Proc. Nat. Acad. Sci. USA 78, 2335-2339.
Liu, S., Derick, L. H. and Palek, J. (1987). Visualization of the hexagonal
lattice in the erythrocyte membrane skeleton. J. Cell Biol. 104, 527-536.
Liu, X., Seno, K., Nishizawa, Y., Hayashi, F., Yamazaki, A., Matsumoto,
H., Wakabayashi, T. and Usukura, J. (1994). Ultrastructural localization
of retinal guanylate cyclase in human and monkey retinas. Exp. Eye Res. 59,
761-768.
Lolley, R. N. and Racz, E. (1982). Calcium modulation of cyclic GMP
synthesis in rat visual cells. Vision Res. 22, 1481-1486.
Lowe, D. G., Dizhoor, A. M., Liu, K., Gu, Q., Spencer, M., Laura, R., Lu, L.
and Hurley, J. B. (1995). Cloning and expression of a second photoreceptor-
specific membrane retina guanylyl cyclase (RetGC), RetGC-2. Proc. Nat.
Acad. Sci. USA 92, 5535-5539.
Miyaguchi, K. and Hashimoto, P. H. (1992). Evidence for the transport of
opsin in the connecting cilium and basal rod outer segment in rat retina:
rapid-freeze, deep-etch and horseradish peroxidase labelling studies. J.
Neurocytol. 21, 449-457.
Molday, R. S., Hicks, D. and Molday, L. L. (1987). Peripherin. A rim-specific
membrane protein of rod outer segments. Invest. Ophthalmol. Vis. Sci. 28,
50-61.
Molday, R. S. and Molday, L. L. (1987). Difference in the protein
composition of bovine retinal rod outer segment disk and plasma membrane
isolated by a ricin-gold-dextran density perturbation method. J. Cell Biol.
105, 2589-2601.
Nir, I. and Papermaster, D. S. (1983). Differential distribution of opsin in the
plasma membrane of frog photoreceptors: an immunocytochemical study.
Invest. Ophthalmol. Vis. Sci. 24, 868-878.
Nir, I., Cohen, D. and Papermaster, D. S. (1984). Immunocytochemical
localization of opsin in the cell membrane of developing rat retinal
photoreceptors. J. Cell Biol. 98, 1788-1795.
Olmsted, J. B. (1986). Analysis of cytoskeletal structures using blot-purified
monospecific antibodies. Meth. Enzymol. 134, 467-472.
Palczewski, K., Subbaraya, I., Gorczyca, W. A., Helekar, B. S., Ruiz, C. C.,
Ohguro, H., Huang, J., Zhao, X., Crabb, J. W., Johnson, R. S., Walsh, K.
A., Gray-Keller, M. P., Detwiler, P. B. and Baehr, W. (1994). Molecular
cloning and characterization of retinal photoreceptor guanylyl cyclase-
activating protein. Neuron 13, 395-404.
Pardee, J. and Spudich, J. (1982). Purification of muscle actin. Meth.
Enzymol. 85, 164-181.
Pepe, I. M., Panfoli, I. and Cugnoli, C. (1986). Guanylate cyclase in rod outer
segments of the toad retina. FEBS Lett. 203, 73-76.
Pinder, J. and Gratzer, W. (1983). Structural and dynamic states of actin in
the erythrocyte. J. Cell Biol. 96, 768-775.
Pozdnyakov, N., Yoshida, A., Cooper, N. G. F., Margulis, A., Duda, T.,
Sharma, R. K. and Sitaramayya, A. (1995). A novel calcium-dependent
activator of retinal rod outer segment membrane guanylate cyclase.
Biochemistry 34, 14279-14283.
Röhlich, P., Adamus, G., McDowell, J. H. and Hargrave, P. H. (1989).
Binding pattern of anti-rhodopsin monoclonal antibodies to photoreceptor
cells: an immunocytochemical study. Exp. Eye Res. 49, 999-1013.
Rozdzial, M. M., Neighbors, B. W. and McIntosh, J. R. (1990). Blot overlay
1812 M. A. Hallett and othersidentification of microtubule-binding peptides from bovine brain. Eur. J.
Cell Biol. 27-35.
Shyjan, A. W., de Sauvage, F. J., Gillett, N. A., Goeddel, D. V. and Lowe, D.
G. (1992). Molecular cloning of a retina-specific membrane guanylyl
cyclase. Neuron 9, 727-737.
Tam, J. P. (1988). Synthetic peptide vaccine design: synthesis and properties
of high-density multiple peptide antigenic peptide system. Proc. Nat. Acad.
Sci. USA 85, 5409-5413.
Usukura, J. and Bok, D. (1987). Changes in the localization and content of
opsin during retinal development in the rds mutant mouse:
immunocytochemistry and immunoassay. Exp. Eye. Res. 45, 501-515.
Van Bergen en Henegouwen, P. M. P., Defize, L. H. K., de Kroon, J., van
Damme, H., Verkleij, A. J. and Boonsta, J. (1989). Ligand-induced
association of epidermal growth factor receptor to the cytoskeleton of A431
cells. J. Cell. Biochem. 39, 455-465.
Walker, J., Boustead, C. and Witzemann, V. (1984). The 43-K protein, v1,
associated with acetylcholine receptor containing membrane fragments is an
actin-binding protein. EMBO J. 3, 2287-2290.Wiegant, F. A. C., Blok, F. J., Defize, L. H. K., Linnemans, W. A. M.,
Verkley, A. J. and Boonstra, J. (1986). Epidermal growth factor receptors
associated to cytoskeletal elements of epidermoid carcinoma (A431) cells. J.
Cell Biol. 103, 87-94.
Williams, D. S., Arikawa, K. and Paallysaho, T. (1990). Cytoskeletal
components of the adherens junctions between the photoreceptors and the
supportive Muller cells. J. Comp. Neurol. 295, 155-164.
Williams, D. S. (1991). Actin filaments and photoreceptor membrane turnover.
BioEssays 13, 171-178.
Yang, R.-B., Foster, D. C., Garbers, D. L. and Fulle, H.-J. (1995). Two
membrane forms of guanylyl cyclase found in the eye. Proc. Nat. Acad. Sci.
USA 92, 602-606.
Yarfitz, S. and Hurley, J. B. (1994). Transduction mechanisms of vertebrate
and invertebrate photoreceptors. J. Biol. Chem. 269, 14329-14332.
(Received 26 January 1996 - Accepted 18 April 1996)
